Company Name:InflaRx N.V.
CEO: Niels Riedemann

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: InflaRx NV is a biopharmaceutical company. It discovers and develops potent and specific inhibitors of the complement activation factor known as C5a.


Key numbers

Market Capitalization:95022200
Shares Outstanding: 26105000
Float: 17966270
Next Earning Date:2020-03-26
TTm EPS: -2.1633
TTm Dividend Rate:
200 days moving average:11.49
50 days moving average: 3.39
One day percent Change: -6.59



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,